Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2024-05-16 00:00:00 ET · period of report 2024-05-14 · accession 0001822629-24-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-16 | 2024-05-14 | ANIP | Lalwani Nikhil | Pres, CEO, Dir | S - Sale | $66.10 | -16.7K | 377.5K | -4% | -$1.10M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-14 | S | D | 16,669 | $66.10 | 377,505 | D | — | — | (F1) The shares were sold in multiple trades at prices ranging from $65.67 to $67.56. The price reported above reflects the weighted average sales price. |